Abstract:Abstract Background The treatment of complex diseases by taking multiple drugs becomes increasingly popular. However, drug-drug interactions (DDIs) may give rise to the risk of unanticipated adverse effects and even unknown toxicity. DDI detection in the wet lab is expensive and time-consuming. Thus, it is highly desired to develop the computational methods for predicting DDIs. Generally, most of the existing computational methods predict DDIs by extracting the chemical and biological features of drugs from diverse drug-related properties, however some drug properties are costly to obtain and not available in many cases. Results In this work, we presented a novel method (namely DPDDI) to predict DDIs by extracting the network structure features of drugs from DDI network with graph convolution network (GCN), and the deep neural network (DNN) model as a predictor. GCN learns the low-dimensional feature representations of drugs by capturing the topological relationship of drugs in DDI network. DNN predictor concatenates the latent feature vectors of any two drugs as the feature vector of the corresponding drug pairs to train a DNN for predicting the potential drug-drug interactions. Experiment results show that, the newly proposed DPDDI method outperforms four other state-of-the-art methods; the GCN-derived latent features include more DDI information than other features derived from chemical, biological or anatomical properties of drugs; and the concatenation feature aggregation operator is better than two other feature aggregation operators (i.e., inner product and summation). The results in case studies confirm that DPDDI achieves reasonable performance in predicting new DDIs. Conclusion We proposed an effective and robust method DPDDI to predict the potential DDIs by utilizing the DDI network information without considering the drug properties (i.e., drug chemical and biological properties). The method should also be useful in other DDI-related scenarios, such as the detection of unexpected side effects, and the guidance of drug combination.

TMFUF: a Triple Matrix Factorization-Based Unified Framework for Predicting Comprehensive Drug-Drug Interactions of New Drugs

Drug-Target Interaction Prediction Based on Multi-Similarity Fusion and Sparse Dual-Graph Regularized Matrix Factorization.

Multi-Label Robust Factorization Autoencoder and its Application in Predicting Drug-Drug Interactions

ISCMF: Integrated similarity-constrained matrix factorization for drug–drug interaction prediction

Multitype drug interaction prediction based on the deep fusion of drug features and topological relationships

Drug–drug interaction prediction: databases, web servers and computational models

DeepMPF: deep learning framework for predicting drug–target interactions based on multi-modal representation with meta-path semantic analysis

Identification of Drug-Drug Interactions Using Chemical Interactions

A Molecular Fragment Representation Learning Framework for Drug–Drug Interaction Prediction

HF-DDI: Predicting Drug-Drug Interaction Events Based on Multimodal Hybrid Fusion

Analysis and prediction of drug–drug interaction by minimum redundancy maximum relevance and incremental feature selection

Prediction of multiple types of drug interactions based on multi-scale fusion and dual-view fusion

Identification of drug-target interactions via multiple kernel-based triple collaborative matrix factorization

DPDDI: a deep predictor for drug-drug interactions

MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction

An Integration Framework of Secure Multiparty Computation and Deep Neural Network for Improving Drug-Drug Interaction Predictions.

Multiple Similarity Drug-Target Interaction Prediction with Random Walks and Matrix Factorization

A Review of Approaches for Predicting Drug–Drug Interactions Based on Machine Learning

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

Collaborative Matrix Factorization with Multiple Similarities for Predicting Drug-Target Interactions

Molecular Structure-Based Double-Central Drug-Drug Interaction Prediction